Table 4:
Correlation among markers of inflammation, immune activation and oxidized lipids in infants
| Correlatio n coefficient (p-value) |
D Dimer | IL6 | IP10 | Ox_L DL_ |
sTNF- RI |
sTNF- RII |
VCAM | hsCRP | sCD14 | sCD163 |
|---|---|---|---|---|---|---|---|---|---|---|
| D Dimer | 0.00 (0.99) |
0.07 (0.36) |
0.05 (0.49) |
0.21
(0.01) |
0.19
(0.01) |
0.16
(0.04) |
0.11 (0.14) |
0.17 (0.03) |
0.09 (0.26) |
|
| IL6 | 0.04 (0.64) |
0.19
(0.01) |
−0.01 (0.86) |
0.10 (0.18) |
0.04 (0.62) |
0.19
(0.01) |
0.34
(<.001) |
0.33
(<.001) |
0.18
(0.02) |
|
| IP10 | −0.10 (0.22) |
0.16
(0.05) |
−0.03 (0.74) |
0.24
(0.002) |
0.31
(<.001) |
0.48
(<.001) |
−0.04 (0.60) |
0.27
(<.001) |
0.13 (0.10) |
|
| Ox_LDL |
0.20
(0.01) |
0.18
(0.02) |
0.14 (0.08) |
−0.12 (0.13) |
−0.01 (0.87) |
−0.08 (0.27) |
−0.00 (0.99) |
0.12 (0.11) |
−0.04 (0.60) |
|
| sTNF-RI | 0.13 (0.11) |
0.37
(<.001) |
0.27
(<.001) |
0.23
(0.002) |
0.33
(<.001) |
0.34
(<.001) |
0.13 (0.08) |
0.19
(0.01) |
0.36
(<.001) |
|
| sTNF-RII | 0.10 (0.20) |
−0.02 (0.76) |
0.08 (0.31) |
0.07 (0.36) |
0.22
(0.004) |
0.46
(<.001) |
0.15 (0.06) |
0.28
(<.001) |
0.26
(<.001) |
|
| VCAM |
0.18
(0.03) |
0.12 (0.12) |
−0.13 (0.09) |
−0.17
(0.03) |
0.08 (0.29) |
0.12 (0.12) |
0.05 (0.51) |
0.25
(<.001) |
0.32
(<.001) |
|
| hsCRP | 0.11 (0.18) |
0.16
(0.03) |
0.31
(<.001) |
0.32
(<.001) |
0.36
(<.001) |
0.14 (0.07) |
−0.03 (0.70) |
0.38
(<.001) |
0.21
(0.01) |
|
| sCD14 | 0.05 (0.55) |
0.14 (0.07) |
0.27
(<.001) |
0.37
(<.001) |
0.27
(<.001) |
0.07 (0.35) |
−0.19
(0.01) |
0.48
(<.001) |
0.32
(<.001) |
|
| sCD163 | −0.06 (0.45) |
0.00 (0.98) |
0.12 (0.11) |
0.03 (0.67) |
−0.01 (0.94) |
0.20
(0.01) |
0.05 (0.53) |
0.20
(0.01) |
0.24
(0.002) |
Pearson correlation coefficients were calculated between all pairs of markers, both at infants’ birth (results reported below diagonal) and the 6 month visit (results reported above diagonal), with HEU and HU infants combined.